September 21, 2016
TB Alliance Statement on the UN’s Declaration on Antimicrobial Resistance
From Declaration to Action
August 25, 2016
SciDev: Children Getting their Own Anti-TB Drugs Soon
Countries are racing to rollout new child-friendly medicines
June 21, 2016
TB Alliance and Takeda Announce Advancement of Joint Program Investigating Promising Compounds for Novel TB Therapies
March 23, 2016
Louder Than TB: TB Alliance joins health leaders to call attention to burden of childhood TB
Working together, we can give voice to the voiceless
March 11, 2016
Phase 1 Clinical Trial of TB Drug Candidate TBA-354 Discontinued
More investment is needed to expand the portfolio of new TB drug candidates
January 4, 2016
Phase 1 TBA-354 Placed on Clinical Hold
TB Alliance announced today that it has voluntarily halted further dosing of TBA-354 in the ongoing Multiple Ascending Dose (MAD) Phase 1 study.
November 24, 2015
TB Alliance and Partners Announce World’s First Availability of Appropriate, Child-friendly TB Medicines in Correct Doses
October 28, 2015